Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.

Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their blockbuster weight ...

High-fiber fall foods, such as apples, sweet potatoes, and Brussels sprouts, highlight the best of the season and also help ...

It is possible to eat candy when you have type 1 or type 2 diabetes. Learn about the best choices for your situation, and how ...

Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers and severe pain for six years. She ...

Eli Lilly and Novo Nordisk have become the latest pharma giants to strike price-reduction deals with the White House, agreeing to sell their weight loss drugs at cut-rate prices to patients in the U.S ...

The deal offers popular weight loss drugs to be sold for as low as $149 on President Donald Trump's direct-to-consumer ...